Cardiac dysfunction and remodeling regulated by anti-angiogenic environment in patients with preeclampsia: the...

Area of Science:

• Obstetrics and Gynecology
• Cardiology
• Perinatology

Background:

• Cardiovascular diseases (CVD) remain a leading cause of mortality despite advances in diagnosis and treatment.
• Pregnancy significantly impacts the maternal cardiovascular system, with preeclampsia (PE) increasing long-term CVD risk up to fourfold.
• An anti-angiogenic environment is implicated in PE, but its connection to maternal cardiovascular complications requires further research.

Purpose of the Study:

• To investigate the association between angiogenic factors and maternal cardiac dysfunction or remodeling in women with preeclampsia.
• To determine if novel cardiac biomarkers and echocardiography can detect these changes.
• To evaluate the long-term cardiovascular impact of PE on maternal health.

Main Methods:

• A prospective cohort study involving 440 high-risk pregnant women, women with diagnosed PE, and healthy controls.
• Assessment of placental biochemical and biophysical cardiovascular markers in the first and third trimesters.
• Maternal and fetal echocardiography in the third trimester, with maternal cardiac function reassessed 12 months postpartum.

Main Results:

• The study is designed to characterize the relationship between anti-angiogenic factors and maternal cardiovascular dysfunction during and after pregnancy.
• It will correlate angiogenic markers and echocardiographic findings with PE status and long-term cardiovascular risk.
• Fetal cardiac function will be evaluated and correlated with maternal variables.

Conclusions:

• This research will elucidate the link between an anti-angiogenic state and maternal cardiovascular complications in PE.
• The findings are expected to enhance the understanding of future CVD risk in women with a history of PE.
• The ultimate goal is to improve cardiovascular health outcomes for women affected by PE, thereby reducing disease burden.